All told, Lilly stock still gained 33% in 2024, outperforming the S&P 500 and Nasdaq Composite. Unfortunately, Lilly ...

Eli Lilly's stock dipped due to cutting Q4 sales targets, despite a strong 2024 performance from Mounjaro and Zepbound. Click ...

There is always going to be a need for advancements in healthcare and for companies to develop new drugs, and Eli Lilly has proven to be a leader on both fronts, which is why it can be one of the ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn’t one of them. The 10 stocks that made the cut ...

As for the GLP-1 stocks not named Eli Lilly that are also falling today, the news there may be even better. Again, on the one hand ... our expert team of analysts issues a “Double Down ...

Scorpion Therapeutics Inc. is selling its lead drug in testing for breast cancer and other advanced solid tumors, to Eli ...

Eli Lilly and Company (NYSE:LLY) 43rd Annual J.P. Morgan Healthcare Conference January 14, 2025 5:15 PM ETCompany ParticipantsDave Ricks - Chairman ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are two of the most valuable healthcare stocks in the world, largely due ...

Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss ...

LONDON, Dec 23 (Reuters) - Eli Lilly's (LLY.N), opens new tab obesity ... for people with at least one weight-related condition, such as heart disease or type-2 diabetes, and a body mass index ...

Summit Partners, a leading growth-focused investment firm, is pleased to announce the addition of Ricardo Gonzalez as a Partner on the firm’s Growth P ...